Baumgartner Jeffrey W
EVP, R&D at CRUS
- Sold, on record
- $14.6M
- Dollars the filings state
- Form 4 sales
- 18
- Latest Sep 21, 2026
- Form 144 notices
- 3
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CRUSCIRRUS LOGIC, INC.EVP, R&D
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale CRUSRoutineSep 17, 2025 2025
Sold 9,162 shares at $120.00 ($1.1M)
Baumgartner Jeffrey W, EVP, R&D
10b5-1 planSold 39.6% of holdings ($2.8M position)14,001 shares left1.2x usual sizeFiling
- 2 Form 4 sale CRUSRoutineMay 29, 2026 +254 days
Sold 11,171 shares at $171.65 ($1.9M)
Baumgartner Jeffrey W, EVP, R&D
10b5-1 planSold 38.9% of holdings ($4.9M position)17,575 shares left1.2x usual sizeFiling
- 3 Form 4 sale CRUSRoutineJun 2, 2026 +4 days
Sold 3,907 shares at $168.54 ($658k)
Baumgartner Jeffrey W, EVP, R&D
10b5-1 planSold 18.2% of holdings ($3.6M position)17,575 shares left0.4x usual sizeFiling
- 4 Form 4 sale CRUSRoutineJun 22, 2026 +20 days
Sold 1,170 shares at $168.23 ($197k)
Baumgartner Jeffrey W, EVP, R&D
10b5-1 planSold 6.7% of holdings ($3M position)16,405 shares left0.1x usual sizeFiling
- 5 Form 4 sale CRUSRoutineJul 1, 2026 +9 days
Sold 1,458 shares at $145.97 ($213k)
Baumgartner Jeffrey W, EVP, R&D
10b5-1 planSold 8.2% of holdings ($2.6M position)16,405 shares left0.2x usual sizeFiling
- 6 Form 4 sale CRUSRoutineJul 20, 2026 +19 days
Sold 1,166 shares at $138.57 ($162k)
Baumgartner Jeffrey W, EVP, R&D
10b5-1 planSold 7.1% of holdings ($2.3M position)15,239 shares left0.2x usual sizeFiling
- 7 Form 4 sale CRUSRoutineAug 20, 2026 +31 days
Sold 1,166 shares at $117.89 ($137k)
Baumgartner Jeffrey W, EVP, R&D
10b5-1 planSold 7.7% of holdings ($1.8M position)14,073 shares left0.2x usual sizeFiling
- 8 Form 4 sale CRUSRoutineSep 21, 2026 +32 days
Sold 1,166 shares at $119.00 ($139k)
Baumgartner Jeffrey W, EVP, R&D
10b5-1 planSold 8.3% of holdings ($1.7M position)12,907 shares left0.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (21)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Sep 23, 2026 | CRUS | EVP, R&D | Form 4 sale | 1,166 | $139k | 8.3% | Routine | SEC |
| Aug 20, 2026 | Aug 24, 2026 | CRUS | EVP, R&D | Form 4 sale | 1,166 | $137k | 7.7% | Routine | SEC |
| Jul 20, 2026 | Jul 21, 2026 | CRUS | EVP, R&D | Form 4 sale | 1,166 | $162k | 7.1% | Routine | SEC |
| Jul 1, 2026 | Jul 2, 2026 | CRUS | EVP, R&D | Form 4 sale | 1,458 | $213k | 8.2% | Routine | SEC |
| Jun 22, 2026 | Jun 24, 2026 | CRUS | EVP, R&D | Form 4 sale | 1,170 | $197k | 6.7% | Routine | SEC |
| Jun 2, 2026 | Jun 4, 2026 | CRUS | EVP, R&D | Form 4 sale | 3,907 | $658k | 18.2% | Routine | SEC |
| May 29, 2026 | Jun 2, 2026 | CRUS | EVP, R&D | Form 4 sale | 11,171 | $1.9M | 38.9% | Routine | SEC |
| Sep 17, 2025 | Sep 18, 2025 | CRUS | EVP, R&D | Form 4 sale | 9,162 | $1.1M | 39.6% | Routine | SEC |
| Sep 2, 2025 | Sep 3, 2025 | CRUS | EVP, R&D | Form 4 sale | 10,000 | $1.1M | 41.7% | Routine | SEC |
| Jun 3, 2025 | Jun 5, 2025 | CRUS | EVP, R&D | Form 4 sale | 10,000 | $1M | 41.7% | Routine | SEC |
| Jun 3, 2025 | Jun 3, 2025 | CRUS | Officer | Form 144 notice | 10,000 | $1M | Notice | SEC | |
| Feb 3, 2025 | Feb 5, 2025 | CRUS | EVP, R&D | Form 4 sale | 2,051 | $205k | 19.8% | Routine | SEC |
| Feb 3, 2025 | Feb 3, 2025 | CRUS | Officer | Form 144 notice | 2,051 | $205k | Notice | SEC | |
| Nov 19, 2024 | Nov 20, 2024 | CRUS | VP, R&D | Form 4 sale | 5,542 | $560k | 34.8% | Routine | SEC |
| Nov 19, 2024 | Nov 19, 2024 | CRUS | Officer | Form 144 notice | 5,542 | $560k | Notice | SEC | |
| Mar 1, 2022 | Mar 3, 2022 | CRUS | VP, R&D | Form 4 sale | 13,593 | $1.2M | 81.5% | Unusual | SEC |
| Jan 3, 2022 | Jan 5, 2022 | CRUS | VP, R&D | Form 4 sale | 20,000 | $1.9M | 86.6% | Unusual | SEC |
| Nov 2, 2021 | Nov 4, 2021 | CRUS | VP, R&D | Form 4 sale | 25,290 | $2.1M | 100.0% | Unusual | SEC |
| Jun 15, 2021 | Jun 16, 2021 | CRUS | VP of R&D | Form 4 sale | 2,500 | $200k | 9.0% | Plan not stated | SEC |
| Nov 9, 2020 | Nov 10, 2020 | CRUS | VP of R&D | Form 4 sale | 7,186 | $543k | 43.6% | Unusual | SEC |
| Oct 6, 2020 | Oct 8, 2020 | CRUS | VP of R&D | Form 4 sale | 19,270 | $1.3M | 66.5% | Unusual | SEC |